Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1989 1
1994 1
1997 1
1999 1
2001 1
2002 1
2006 1
2007 1
2008 2
2009 1
2010 1
2011 3
2013 1
2015 3
2016 3
2017 2
2018 4
2019 4
2020 4
2021 3
2022 6
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children.
Minard-Colin V, Aupérin A, Pillon M, Burke GAA, Barkauskas DA, Wheatley K, Delgado RF, Alexander S, Uyttebroeck A, Bollard CM, Zsiros J, Csoka M, Kazanowska B, Chiang AK, Miles RR, Wotherspoon A, Adamson PC, Vassal G, Patte C, Gross TG; European Intergroup for Childhood Non-Hodgkin Lymphoma; Children’s Oncology Group. Minard-Colin V, et al. N Engl J Med. 2020 Jun 4;382(23):2207-2219. doi: 10.1056/NEJMoa1915315. N Engl J Med. 2020. PMID: 32492302 Free PMC article. Clinical Trial.
Nivolumab and brentuximab vedotin with or without bendamustine for R/R Hodgkin lymphoma in children, adolescents, and young adults.
Harker-Murray P, Mauz-Körholz C, Leblanc T, Mascarin M, Michel G, Cooper S, Beishuizen A, Leger KJ, Amoroso L, Buffardi S, Rigaud C, Hoppe BS, Lisano J, Francis S, Sacchi M, Cole PD, Drachtman RA, Kelly KM, Daw S. Harker-Murray P, et al. Among authors: buffardi s. Blood. 2023 Apr 27;141(17):2075-2084. doi: 10.1182/blood.2022017118. Blood. 2023. PMID: 36564047 Free PMC article. Clinical Trial.
HLA-G+3027 polymorphism is associated with tumor relapse in pediatric Hodgkin's lymphoma.
De Re V, Caggiari L, Mussolin L, d'Amore ES, Famengo B, De Zorzi M, Martina L, Elia C, Pillon M, Santoro N, Muggeo P, Buffardi S, Bianchi M, Sala A, Farruggia P, Vinti L, Carosella ED, Burnelli R, Mascarin M. De Re V, et al. Among authors: buffardi s. Oncotarget. 2017 Nov 18;8(62):105957-105970. doi: 10.18632/oncotarget.22515. eCollection 2017 Dec 1. Oncotarget. 2017. PMID: 29285306 Free PMC article.
Brentuximab vedotin in the treatment of paediatric patients with relapsed or refractory Hodgkin's lymphoma: Results of a real-life study.
Massano D, Carraro E, Mussolin L, Buffardi S, Barat V, Zama D, Muggeo P, Vendemini F, Sau A, Moleti ML, Verzegnassi F, D'Amico S, Casini T, Garaventa A, Schiavello E, Cellini M, Vinti L, Farruggia P, Perruccio K, Cesaro S, De Santis R, Marinoni M, D'Alba I, Mura RM, Burnelli R, Mascarin M, Pillon M. Massano D, et al. Among authors: buffardi s. Pediatr Blood Cancer. 2022 Oct;69(10):e29801. doi: 10.1002/pbc.29801. Epub 2022 Jun 2. Pediatr Blood Cancer. 2022. PMID: 35656841
Comparison of Hodgkin's Lymphoma in Children and Adolescents. A Twenty Year Experience with MH'96 and LH2004 AIEOP (Italian Association of Pediatric Hematology and Oncology) Protocols.
Burnelli R, Fiumana G, Rondelli R, Pillon M, Sala A, Garaventa A, D'Amore ESG, Sabattini E, Buffardi S, Bianchi M, Vinti L, Zecca M, Muggeo P, Provenzi M, Farruggia P, Rossi F, D'Amico S, Facchini E, Bernasconi S, De Santis R, Casini T, Porta F, D'Alba I, Mura R, Verzegnassi F, Sau A, Cesaro S, Perruccio K, Cellini M, Bertolini P, Sperlì D, Pericoli R, Galimberti D, Civino A, Mascarin M. Burnelli R, et al. Among authors: buffardi s. Cancers (Basel). 2020 Jun 18;12(6):1620. doi: 10.3390/cancers12061620. Cancers (Basel). 2020. PMID: 32570974 Free PMC article.
Outcome of Children and Adolescents with Recurrent Classical Hodgkin Lymphoma: The Italian Experience.
Garaventa A, Parodi S, Guerrini G, Farruggia P, Sala A, Pillon M, Buffardi S, Rossi F, Bianchi M, Zecca M, Vinti L, Facchini E, Casini T, Bernasconi S, Amoroso L, D'Amico S, Provenzi M, De Santis R, Sau A, Muggeo P, Mura RM, Haupt R, Mascarin M, Burnelli R. Garaventa A, et al. Among authors: buffardi s. Cancers (Basel). 2022 Mar 13;14(6):1471. doi: 10.3390/cancers14061471. Cancers (Basel). 2022. PMID: 35326622 Free PMC article.
Brentuximab vedotin in combination with bendamustine in pediatric patients or young adults with relapsed or refractory Hodgkin lymphoma.
Vinti L, Pagliara D, Buffardi S, Di Ruscio V, Stocchi F, Mariggiò E, Parasole R, Di Matteo A, Petruzziello F, Paganelli V, De Vito R, Del Bufalo F, Strocchio L, Locatelli F. Vinti L, et al. Among authors: buffardi s. Pediatr Blood Cancer. 2022 Apr;69(4):e29557. doi: 10.1002/pbc.29557. Epub 2022 Feb 2. Pediatr Blood Cancer. 2022. PMID: 35107876
Prospective Evaluation of Different Methods for Volumetric Analysis on [18F]FDG PET/CT in Pediatric Hodgkin Lymphoma.
Lopci E, Elia C, Catalfamo B, Burnelli R, De Re V, Mussolin L, Piccardo A, Cistaro A, Borsatti E, Zucchetta P, Bianchi M, Buffardi S, Farruggia P, Garaventa A, Sala A, Vinti L, Mauz-Koerholz C, Mascarin M. Lopci E, et al. Among authors: buffardi s. J Clin Med. 2022 Oct 21;11(20):6223. doi: 10.3390/jcm11206223. J Clin Med. 2022. PMID: 36294544 Free PMC article.
42 results